
China Pharma Holdings, Inc.
CPHI
CPHI: China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
moreShow CPHI Financials
Recent trades of CPHI by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CPHI's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CPHI's company Twitter account
Number of mentions of CPHI in WallStreetBets Daily Discussion
Recent insights relating to CPHI
Recent picks made for CPHI stock on CNBC
ETFs with the largest estimated holdings in CPHI
Flights by private jets registered to CPHI